Prurigo pigmentosa
I-Prurigo pigmentosa yimeko yesikhumba engaziwayo, ebonakaliswa ngokukhawuleza kwe‑erythematous papules ezishiya i‑hyperpigmentation edibeneyo xa iphilile. Ngamanye amaxesha le meko ibangelwa kukutya okungahambelani kwangoko.
☆ AI Dermatology — Free Service
Kwiziphumo zika-2022 ze-Stiftung Warentest ezivela eJamani, ukwaneliseka kwabathengi ngeModelDerm bekungaphantsi kancinci kunokubonisana nge-telemedicine ehlawulweyo.
Kwiziphumo zika-2022 ze-Stiftung Warentest ezivela eJamani, ukwaneliseka kwabathengi ngeModelDerm bekungaphantsi kancinci kunokubonisana nge-telemedicine ehlawulweyo.
relevance score : -100.0%
ReferencesPrurigo pigmentosa yimeko yesikhumba engqabileyo evuthayo echazwe okokuqala nguNagashima et al ngo‑1971. Ichaphazela kakhulu abafazi abancinci abavela e‑East Asia, kodwa ingenzeka nakwabanye. Ibonisa njengemigca elinganayo yamaqhuma abomvu aphakamileyo entanyeni, esifubeni, nasemva. La maqhuma adala ipateni efana nomnatha, alandelelanayo, eshiya amabala amnyama esikhumbeni. Prurigo pigmentosa inokubangelwa utshintsho kwi‑metabolism, njengalezo ezibangelwa ukutya kwe‑ketogenic diet, okwaziwa kakhulu kutshanje.
Prurigo pigmentosa, also known as Nagashima disease or keto rash, is a rare inflammatory skin disease initially described by Nagashima et al in 1971. Prurigo pigmentosa typically, but not exclusively, affects young females of East Asian ethnicity, presenting as a symmetrical eruption of urticarial papules on the neck, chest, and back. The papular eruption typically coalesces into a reticulated pattern that repeatedly resolves and recurs, resulting in hyperpigmented skin of cosmetic concern. Prurigo pigmentosa can be triggered by metabolic derangements, including those secondary to ketogenic diets, which have experienced a rise in popularity in recent years.
Prurigo pigmentosa, also known as Nagashima disease or keto rash, is a rare inflammatory skin disease initially described by Nagashima et al in 1971. Prurigo pigmentosa typically, but not exclusively, affects young females of East Asian ethnicity, presenting as a symmetrical eruption of urticarial papules on the neck, chest, and back. The papular eruption typically coalesces into a reticulated pattern that repeatedly resolves and recurs, resulting in hyperpigmented skin of cosmetic concern. Prurigo pigmentosa can be triggered by metabolic derangements, including those secondary to ketogenic diets, which have experienced a rise in popularity in recent years.
Prurigo pigmentosa yimeko yolusu ebangela ukungakhululeki, ukuqumba, kunye namaqhuma abomvu ngokwepateni afana nomnatha, elandelwa ngamabala amnyama. Kungekudala, ubungqina buveza ukuba Prurigo pigmentosa idibene nokutya kwe‑ketogenic. Inokuchaphazela abantu abaneminyaka eyahlukeneyo kunye nesini, kunye nokunyuka kokuxhaphaka kwabasetyhini. Kwiimeko apho ukubuyela kwisidlo esiqhelekileyo okanye ukusebenzisa unyango lwesikhumba kungekhona yanele, oogqirha banokuncoma umkhombandlela womlomo wokubulala iintsholongwane, njenge‑doxycycline okanye i‑minocycline (100 mg kabini yonke imihla, imihla‑ebini ukuya kwiinyanga ezili‑1‑2).
Prurigo pigmentosa is a skin condition causing sudden, itchy, red bumps in a net-like pattern followed by dark spots. Lately, some evidences were founded that Prurigo pigmentosa is associated with the ketogenic diet. It can affect people of different ages and genders, with a tendency to be more common in females. In cases where returning to a regular diet or using skin treatments doesn't fully help, doctors may prescribe a course of oral antibiotics like doxycycline or minocycline (100 mg twice daily for 1 to 2 months).
Prurigo pigmentosa is a skin condition causing sudden, itchy, red bumps in a net-like pattern followed by dark spots. Lately, some evidences were founded that Prurigo pigmentosa is associated with the ketogenic diet. It can affect people of different ages and genders, with a tendency to be more common in females. In cases where returning to a regular diet or using skin treatments doesn't fully help, doctors may prescribe a course of oral antibiotics like doxycycline or minocycline (100 mg twice daily for 1 to 2 months).
